NCT03006809View on ClinicalTrials.gov

Optimal Fecal Microbiota Transplant Dosing for Mild to Moderate Ulcerative Colitis

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 2, 2017

Primary Completion Date

May 4, 2020

Study Completion Date

April 4, 2021

Conditions
Ulcerative Colitis
Interventions
BIOLOGICAL

Fecal Microbiota Transplantation (FMT), OpenBiome

Delivered by colonoscopy, enema or orally (as capsules)

OTHER

pretreatment antibiotics

5 day course (vancomycin PO 500mg bid, metronidazole PO 500mg bid, and neomycin PO 500mg bid) starting 6 days prior FMT

Trial Locations (1)

94143

UCSF Division of Gastroenterology at Mount Zion, San Francisco

All Listed Sponsors
lead

Najwa Elnachef

OTHER

NCT03006809 - Optimal Fecal Microbiota Transplant Dosing for Mild to Moderate Ulcerative Colitis | Biotech Hunter | Biotech Hunter